Macrosun Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.50 M
as on 07-12-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 M
as on 07-12-2024
- Revenue 57.53%
(FY 2022)
- Profit 61.36%
(FY 2022)
- Ebitda 8.97%
(FY 2022)
- Net Worth 0.72%
(FY 2022)
- Total Assets 20.16%
(FY 2022)
About Macrosun Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.20 M.
Rahul Sharma and Meenu Sharma serve as directors at the Company.
- CIN/LLPIN
U74999UR2018PTC009226
- Company No.
009226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Macrosun Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Sharma  | Director | 20-Nov-2018 | Current |
| Meenu Sharma | Director | 17-Dec-2022 | Current |
Financial Performance of Macrosun Pharma.
Macrosun Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 57.53% increase. The company also saw a substantial improvement in profitability, with a 61.36% increase in profit. The company's net worth moved up by a moderate rise of 0.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macrosun Pharma?
Unlock access to Macrosun Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Macrolifescience Pharma Private LimitedActive 2 years 25 daysRahul Sharma and Meenu Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Feb 2022 | ₹0.15 M | Open |
State Bank Of India Creation Date: 18 Jun 2020 | ₹0.05 M | Open |
State Bank Of India Creation Date: 18 Jan 2020 | ₹1.00 M | Open |
How Many Employees Work at Macrosun Pharma?
Unlock and access historical data on people associated with Macrosun Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macrosun Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macrosun Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
